Cited by 15Glycogen Storage Diseases and MyoclonusDiabetes Management and ResearchMetabolism and Genetic Disorders

Alternative nighttime nutrition regimens in glycogen storage disease type i: A controlled crossover study

Open access
Hochuli, Michel, Christ, Emanuel, Meienberg, Fabian, Lehmann, Roger, Krützfeldt, Jan, Baumgartner, Matthias R.·2015·Journal of Inherited Metabolic Disease

Abstract

Background: Traditional approaches for nighttime glycemic control in glycogen storage disease type I (GSDI) include continuous tube feeding, or ingestion of uncooked corn starch (CS) at bedtime. A modified corn starch (MCS) has been shown to prolong euglycemia in some patients. The aim of this study was to evaluate whether stable nighttime glucose control can be achieved with other types of slowly digested carbohydrates in adult GSDI patients. Methods: In this cross‐over study, nocturnal glucose control and fasting times were assessed with three different nocturnal nutrition regimens in five patients, using continuous glucose monitoring (CGMS) in an outpatient everyday life setting. For each patient, continuous glucose profiles were measured after ingestion of (1) CS, (2) MCS or (3) a pasta meal at bedtime, during 5 to 6 consecutive nights for each regimen. Results: Stable nocturnal glucose control was achieved for all patients with a pasta meal, with a mean duration of glycemia >3.5 mmol/l of 7.6 h (range 5.7‐10.8), and >4 mmol/l of 7 h (5.2‐9.2), similar to CS and MCS. Fasting glucose before breakfast on workdays (after 7.1 ± 0.8 h) was not significantly different between the three interventions (CS 4.1 ± 0.5 mmol/l, MCS 4.6 ± 0.7 mmol/l, pasta 4.3 ± 0.9 mmol/l). During prolonged fasting on weekends, longer duration of normoglycemia was achieved with CS or MCS than with pasta. Conclusion: Consumption of cooked pasta is a suitable and more palatable alternative to uncooked corn starch to achieve nighttime glucose control in adult patients with GSDI.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10545-015-9864-2

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A 3 mg intranasal glucagon dose (containing 1 mg glucagon per 10 mg powder) seems to produce the maximum effect.

    “Three mg of intranasal glucagon (1 mg glucagon per 10 mg dry powder) appears to have maximal effect.1231–1235”

    From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1233]

    The Results and Discussion (page numbers unavailable) examine nighttime glucose control with cornstarch and pasta in patients with glycogen storage disease type I. Searches for intranasal glucagon, a 3 mg dose, and dry-powder formulation found no passage addressing the claimed maximal effect. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 21 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [5]5. Chen Y-T, Kishnani PS, Koeberl D (2013) Glycogen storage diseases. In: Beaudet AL, Vogelstein B, Kinzler KW et al (eds) The online met- abolic and molecular bases of inherited disease New York. The McGraw-Hill Companies, Inc., NY

Cited by

Sorted by citations

Authors
Hochuli, M., Christ, E., Meienberg, F., Lehmann, R., Krützfeldt, J., & Baumgartner, M. R.
Affiliations
  • University of Zurich (CH)
  • University Hospital of Bern (CH)
  • University Hospital of Basel (CH)
  • University Hospital Zurich (CH)
Corresponding author
Hochuli, Michel
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2015-06-25
Volume
38
Issue
6
Pages
1093-1098
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W798238325
Cited by
15
References
21
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • RERO DOC (Universität Bern) (submittedVersion)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
Universität Zürich
Topics
  • Health Sciences › Medicine › Rheumatology › Glycogen Storage Diseases and Myoclonus
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
glycogen storage disease type I, modified corn starch, fasting blood glucose, continuous glucose monitoring
MeSH terms
Adult, Blood Glucose, Dietary Carbohydrates, Fasting, Female, Glycogen Storage Disease Type I, Humans, Hypoglycemia, Insulin, Male, Starch, Linear Models, Cross-Over Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review